Insys Therapeutics Reports First Quarter 2015 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Insys Therapeutics (INSY) Declares 2-for-1 Stock Split
May 7, 2015 7:10 AM EDTInsys Therapeutics (INSY) declared a 2-for-1 stock split.
The stock split is payable on June 5, 2015 to stockholders of record on May 26, 2015, with an ex-date of June 8, 2015.
Total shares outstanding will increase from approximately 35.7 million to 71.4 million shares.
For stock split history and other stock split-related data on... More
Insys Therapeutics (INSY) Tops Q1 EPS by 23c
May 7, 2015 6:51 AM EDTInsys Therapeutics (NASDAQ: INSY) reported Q1 EPS of $0.63, $0.23 better than the analyst estimate of $0.40. Revenue for the quarter came in at $70.8 million versus the consensus estimate of $70.9 million.
Net income of $8.0 million, or $0.23 per basic and $0.21 per diluted share, compared to net income... More
